(HLT) Hilton Worldwide Holdings - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US43300A2033
Stock: Hotels, Resorts, Brands, Management
Total Rating 65
Risk 71
Buy Signal 0.12
| Risk 5d forecast | |
|---|---|
| Volatility | 25.1% |
| Relative Tail Risk | -0.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.94 |
| Alpha | 12.63 |
| Character TTM | |
|---|---|
| Beta | 0.990 |
| Beta Downside | 1.295 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.35% |
| CAGR/Max DD | 1.16 |
EPS (Earnings per Share)
Revenue
Description: HLT Hilton Worldwide Holdings March 04, 2026
Hilton Worldwide Holdings Inc. (HLT) manages, franchises, and leases hotels and resorts globally. The company operates through two segments: Management and Franchise, and Ownership. The hospitality sector relies heavily on brand recognition and loyalty programs.
HLT’s business model involves licensing its brand names, trademarks, and service marks to property owners. This asset-light approach, common in the modern hotel industry, reduces capital expenditure while expanding market presence.
Its extensive brand portfolio spans luxury, lifestyle, full-service, focused-service, and all-suites categories. This diversification allows HLT to target various customer segments and adapt to market demand fluctuations.
Geographically, HLT has operations across North America, South America, Central America, Europe, the Middle East, Africa, and Asia Pacific. Understanding specific market performance within these regions can offer further insights.
Headlines to watch out for
- Global travel demand impacts hotel occupancy and room rates
- Franchise fee growth drives revenue expansion
- Labor costs and supply chain affect operating margins
- Interest rate changes influence development and investment
- Economic downturns reduce leisure and business travel
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 1.46b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 0.85 > 1.0 |
| NWC/Revenue: 20.05% < 20% (prev -12.78%; Δ 32.83% < -1%) |
| CFO/TA 0.13 > 3% & CFO 2.13b > Net Income 1.46b |
| Net Debt (14.70b) to EBITDA (2.87b): 5.12 < 3 |
| Current Ratio: 10.81 > 1.5 & < 3 |
| Outstanding Shares: last quarter (238.0m) vs 12m ago -3.25% < -2% |
| Gross Margin: 41.15% > 18% (prev 0.27%; Δ 4.09k% > 0.5%) |
| Asset Turnover: 72.31% > 50% (prev 67.63%; Δ 4.68% > 0%) |
| Interest Coverage Ratio: 4.34 > 6 (EBITDA TTM 2.87b / Interest Expense TTM 620.0m) |
Altman Z'' 1.64
| A: 0.14 (Total Current Assets 2.66b - Total Current Liabilities 246.0m) / Total Assets 16.77b |
| B: -0.09 (Retained Earnings -1.51b / Total Assets 16.77b) |
| C: 0.16 (EBIT TTM 2.69b / Avg Total Assets 16.65b) |
| D: -0.09 (Book Value of Equity -2.01b / Total Liabilities 22.12b) |
| Altman-Z'' Score: 1.64 = BB |
Beneish M -3.30
| DSRI: 0.99 (Receivables 1.69b/1.58b, Revenue 12.04b/11.17b) |
| GMI: 0.67 (GM 41.15% / 27.41%) |
| AQI: 1.03 (AQ_t 0.77 / AQ_t-1 0.74) |
| SGI: 1.08 (Revenue 12.04b / 11.17b) |
| TATA: -0.04 (NI 1.46b - CFO 2.13b) / TA 16.77b) |
| Beneish M-Score: -3.30 (Cap -4..+1) = AA |
What is the price of HLT shares?
As of March 20, 2026, the stock is trading at USD 297.83 with a total of 1,686,100 shares traded.
Over the past week, the price has changed by +1.21%, over one month by -4.72%, over three months by +1.96% and over the past year by +28.13%.
Over the past week, the price has changed by +1.21%, over one month by -4.72%, over three months by +1.96% and over the past year by +28.13%.
Is HLT a buy, sell or hold?
Hilton Worldwide Holdings has received a consensus analysts rating of 3.62.
Therefor, it is recommend to hold HLT.
- StrongBuy: 7
- Buy: 3
- Hold: 15
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the HLT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 328.2 | 10.2% |
| Analysts Target Price | 328.2 | 10.2% |
HLT Fundamental Data Overview March 20, 2026
P/E Trailing = 48.0522
P/E Forward = 32.8947
P/S = 13.8204
P/EG = 1.4188
Revenue TTM = 12.04b USD
EBIT TTM = 2.69b USD
EBITDA TTM = 2.87b USD
Long Term Debt = 12.34b USD (from longTermDebt, last quarter)
Short Term Debt = 246.0m USD (from shortTermDebt, last quarter)
Debt = 15.67b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 14.70b USD (from netDebt column, last quarter)
Enterprise Value = 83.22b USD (68.47b + Debt 15.67b - CCE 918.0m)
Interest Coverage Ratio = 4.34 (Ebit TTM 2.69b / Interest Expense TTM 620.0m)
EV/FCF = 41.92x (Enterprise Value 83.22b / FCF TTM 1.99b)
FCF Yield = 2.39% (FCF TTM 1.99b / Enterprise Value 83.22b)
FCF Margin = 16.49% (FCF TTM 1.99b / Revenue TTM 12.04b)
Net Margin = 12.10% (Net Income TTM 1.46b / Revenue TTM 12.04b)
Gross Margin = 41.15% ((Revenue TTM 12.04b - Cost of Revenue TTM 7.08b) / Revenue TTM)
Gross Margin QoQ = 76.45% (prev 30.16%)
Tobins Q-Ratio = 4.96 (Enterprise Value 83.22b / Total Assets 16.77b)
Interest Expense / Debt = 1.05% (Interest Expense 165.0m / Debt 15.67b)
Taxrate = 31.47% (135.0m / 429.0m)
NOPAT = 1.85b (EBIT 2.69b * (1 - 31.47%))
Current Ratio = 10.81 (Total Current Assets 2.66b / Total Current Liabilities 246.0m)
Debt / Equity = -2.91 (negative equity) (Debt 15.67b / totalStockholderEquity, last quarter -5.39b)
Debt / EBITDA = 5.12 (Net Debt 14.70b / EBITDA 2.87b)
Debt / FCF = 7.41 (Net Debt 14.70b / FCF TTM 1.99b)
Total Stockholder Equity = -4.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.75% (Net Income 1.46b / Total Assets 16.77b)
RoE = -30.22% (negative equity) (Net Income TTM 1.46b / Total Stockholder Equity -4.82b)
RoCE = 35.83% (EBIT 2.69b / Capital Employed (Equity -4.82b + L.T.Debt 12.34b))
RoIC = 27.54% (NOPAT 1.85b / Invested Capital 6.70b)
WACC = 7.91% (E(68.47b)/V(84.14b) * Re(9.56%) + D(15.67b)/V(84.14b) * Rd(1.05%) * (1-Tc(0.31)))
Discount Rate = 9.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.95%
[DCF] Terminal Value 79.55% ; FCFF base≈1.92b ; Y1≈2.08b ; Y5≈2.59b
[DCF] Fair Price = 134.9 (EV 45.63b - Net Debt 14.70b = Equity 30.93b / Shares 229.3m; r=7.91% [WACC]; 5y FCF grow 9.59% → 2.90% )
EPS Correlation: 73.03 | EPS CAGR: 33.19% | SUE: 0.39 | # QB: 0
Revenue Correlation: 86.76 | Revenue CAGR: 16.86% | SUE: 2.32 | # QB: 3
EPS next Quarter (2026-06-30): EPS=2.44 | Chg7d=+0.005 | Chg30d=-0.060 | Revisions Net=-9 | Analysts=20
EPS current Year (2026-12-31): EPS=9.04 | Chg7d=+0.016 | Chg30d=-0.116 | Revisions Net=-19 | Growth EPS=+11.4% | Growth Revenue=+8.7%
EPS next Year (2027-12-31): EPS=10.42 | Chg7d=-0.001 | Chg30d=-0.111 | Revisions Net=-6 | Growth EPS=+15.3% | Growth Revenue=+8.4%
[Analyst] Revisions Ratio: -0.53 (4 Up / 13 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.5% (Discount Rate 9.6% - Earnings Yield 2.1%)
[Growth] Growth Spread = +0.6% (Analyst 8.1% - Implied 7.5%)
P/E Forward = 32.8947
P/S = 13.8204
P/EG = 1.4188
Revenue TTM = 12.04b USD
EBIT TTM = 2.69b USD
EBITDA TTM = 2.87b USD
Long Term Debt = 12.34b USD (from longTermDebt, last quarter)
Short Term Debt = 246.0m USD (from shortTermDebt, last quarter)
Debt = 15.67b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 14.70b USD (from netDebt column, last quarter)
Enterprise Value = 83.22b USD (68.47b + Debt 15.67b - CCE 918.0m)
Interest Coverage Ratio = 4.34 (Ebit TTM 2.69b / Interest Expense TTM 620.0m)
EV/FCF = 41.92x (Enterprise Value 83.22b / FCF TTM 1.99b)
FCF Yield = 2.39% (FCF TTM 1.99b / Enterprise Value 83.22b)
FCF Margin = 16.49% (FCF TTM 1.99b / Revenue TTM 12.04b)
Net Margin = 12.10% (Net Income TTM 1.46b / Revenue TTM 12.04b)
Gross Margin = 41.15% ((Revenue TTM 12.04b - Cost of Revenue TTM 7.08b) / Revenue TTM)
Gross Margin QoQ = 76.45% (prev 30.16%)
Tobins Q-Ratio = 4.96 (Enterprise Value 83.22b / Total Assets 16.77b)
Interest Expense / Debt = 1.05% (Interest Expense 165.0m / Debt 15.67b)
Taxrate = 31.47% (135.0m / 429.0m)
NOPAT = 1.85b (EBIT 2.69b * (1 - 31.47%))
Current Ratio = 10.81 (Total Current Assets 2.66b / Total Current Liabilities 246.0m)
Debt / Equity = -2.91 (negative equity) (Debt 15.67b / totalStockholderEquity, last quarter -5.39b)
Debt / EBITDA = 5.12 (Net Debt 14.70b / EBITDA 2.87b)
Debt / FCF = 7.41 (Net Debt 14.70b / FCF TTM 1.99b)
Total Stockholder Equity = -4.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.75% (Net Income 1.46b / Total Assets 16.77b)
RoE = -30.22% (negative equity) (Net Income TTM 1.46b / Total Stockholder Equity -4.82b)
RoCE = 35.83% (EBIT 2.69b / Capital Employed (Equity -4.82b + L.T.Debt 12.34b))
RoIC = 27.54% (NOPAT 1.85b / Invested Capital 6.70b)
WACC = 7.91% (E(68.47b)/V(84.14b) * Re(9.56%) + D(15.67b)/V(84.14b) * Rd(1.05%) * (1-Tc(0.31)))
Discount Rate = 9.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.95%
[DCF] Terminal Value 79.55% ; FCFF base≈1.92b ; Y1≈2.08b ; Y5≈2.59b
[DCF] Fair Price = 134.9 (EV 45.63b - Net Debt 14.70b = Equity 30.93b / Shares 229.3m; r=7.91% [WACC]; 5y FCF grow 9.59% → 2.90% )
EPS Correlation: 73.03 | EPS CAGR: 33.19% | SUE: 0.39 | # QB: 0
Revenue Correlation: 86.76 | Revenue CAGR: 16.86% | SUE: 2.32 | # QB: 3
EPS next Quarter (2026-06-30): EPS=2.44 | Chg7d=+0.005 | Chg30d=-0.060 | Revisions Net=-9 | Analysts=20
EPS current Year (2026-12-31): EPS=9.04 | Chg7d=+0.016 | Chg30d=-0.116 | Revisions Net=-19 | Growth EPS=+11.4% | Growth Revenue=+8.7%
EPS next Year (2027-12-31): EPS=10.42 | Chg7d=-0.001 | Chg30d=-0.111 | Revisions Net=-6 | Growth EPS=+15.3% | Growth Revenue=+8.4%
[Analyst] Revisions Ratio: -0.53 (4 Up / 13 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.5% (Discount Rate 9.6% - Earnings Yield 2.1%)
[Growth] Growth Spread = +0.6% (Analyst 8.1% - Implied 7.5%)